Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study.

Autor: Olmez OF; Medical Oncology, Medipol University Faculty of Medicine Medipol Mega Hospital, Bagcilar, Istanbul., Bilici A; Medical Oncology, Medipol University Faculty of Medicine Medipol Mega Hospital, Bagcilar, Istanbul., Er O; Medical Oncology, Acibadem MAA University Acibadem Maslak Hospital, Istanbul., Bisgin A; Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center), Adana & Cukurova Technopolis InfoGenom, Adana., Sevinc A; Medical Oncology, Medical Park Gaziantep Hospital, Gaziantep., Akman T; Medical Oncology, Kent Hospital, Izmir., Uslu R; Medical Oncology, Kent Hospital, Izmir., Mandel NM; Medical Oncology, American Hospital, Istanbul., Yalcin S; Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara., Teomete M; Medical Oncology, Acibadem MAA University Acibadem Altunizade Hospital, Istanbul., Gorumlu G; Medical Oncology, Kent Hospital, Izmir., Demir A; Medical Oncology, Acibadem MAA University Acibadem Maslak Hospital, Istanbul., Namal E; Medical Oncology, Florence Nightingale Sisli Hospital, Istanbul., Alici S; Medical Oncology, Acibadem MAA University Acibadem Altunizade Hospital, Istanbul., Selcukbiricik F; Medical Oncology, Faculty of Medicine, Koc University, Istanbul., Bavbek S; Medical Oncology, American Hospital, Istanbul., Paksoy F; Medical Oncology, Medical Park Goztepe Hospital, Istanbul., Basaran G; Medical Oncology, Acibadem MAA University Acibadem Altunizade Hospital, Istanbul., Ozer L; Medical Oncology, Acıbadem MAA University Acibadem Atakent Hospital, Istanbul., Sener N; Medical Oncology, Florence Nightingale Atasehir Hospital, Istanbul., Harputluoglu H; Medical Oncology, Inonu University Faculty of Medicine, Malatya, Turkey.

Publikováno v: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 May 07; Vol. 54 (5), pp. 562-568.

781P Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab

Autor: Tural, D. ¹, Ölmez, Ö.F. ², Sümbül, A.T. ³, Özhan, N. ⁴, Akar, E. ¹, Çakar, B. ⁵, Köstek, O. ⁶, Ekenel, M. ⁷, Erman, M. ⁸, Çoşkun, H.Ş. ⁹, Selçukbiricik, F. ¹⁰, Keskin, O. ¹¹, Paksoy, F. ⁷, Oruç, K. ¹², S. Bayram ⁹, Yılmaz, U. ⁵, Bilgetekin, I. ¹³, Yıldız, B. ¹⁴, Şendur, M.A.N. ¹⁵, Artac, M. ¹⁶

Publikováno v: In Annals of Oncology September 2020 31 Supplement 4:S598-S598

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

278P - The Impact of Progesterone Receptor on Node-Negative Breast Cancer Survival

Autor: Solak, M. ¹, Paksoy, F. ², Keskin, O. ¹, Kertmen, N. ¹, Altundag, M.K. ¹

Publikováno v: In Annals of Oncology September 2012 23 Supplement 9:ix104-ix105

5096 The discordance between hormonal receptor status and c-erb b2 in primary and metastatic breast cancer

Autor: Tokluoglu, S., Paksoy, F., Arslan, U. Yalçintas, Budakoglu, B., Ulas, A., Celenkoglu, G., Alkis, N.

Publikováno v: In EJC Supplements 2009 7(2):289-289